Page last updated: 2024-10-30

mepivacaine and Coronary Disease

mepivacaine has been researched along with Coronary Disease in 2 studies

Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alam, S1
Sakura, S1
Kosaka, Y1
Lipp, M1
Daubländer, M1

Other Studies

2 other studies available for mepivacaine and Coronary Disease

ArticleYear
Anaesthetic management for caesarean section in a patient with Kawasaki disease.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1995, Volume: 42, Issue:11

    Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Analgesics, Opioid; Anesthesia, Epidural; Anesth

1995
[Aspects of local anesthesia in patients with coronary heart disease].
    Die Quintessenz, 1991, Volume: 42, Issue:6

    Topics: Anesthesia, Dental; Anesthesia, Local; Anesthetics, Local; Coronary Disease; Dental Care for Disable

1991